Bank of Israel signs up for SuperDerivatives

The Bank of Israel, Israel’s central bank, has adopted UK-based technology vendor SuperDerivatives' foreign exchange option pricing and analytics system.

The system can be used to price complex products, as well as providing real-time analysis of the forex market.

“As a central bank, we examine, analyse and research capital flows and exchange rates, particularly, short-term instruments influencing the Israeli shekel, such as currency options,” said Ben Schreiber, head of research in the foreign exchange department at Bank of Israel.

“Few believe the market is about to suddenly stop moving, so it is vital that institutions have the equipment to monitor their foreign exchange risk properly and design and then manage appropriate hedging strategies,” said David Gershon, SuperDerivatives chief executive.

SuperDerivatives adds the central bank to an impressive list of clients, ranging from banks such as Citibank and JP Morgan Chase to corporate treasuries such as IBM and Ford.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here